Table 1 Clinical characteristics of GCMN and normal skin samples
Sample ID | Age, yr | Gender | Location | Experiment |
|---|---|---|---|---|
Normal | Â | |||
Normal 1* | 8 | Male | Face | LC-MS |
Normal 2* | 5 | Female | Face | LC-MS |
Normal 3* | 6 | Female | Face | LC-MS |
Normal 4 | 14 | Female | Forehead | Western blot |
Normal 5 | 11 | Female | Face | Western blot |
Normal 6 | 19 | Female | Forehead | Western blot |
Normal 7 | 36 | Female | Face | Western blot |
Normal 8 | 18 | Female | Face | Western blot |
Normal 9 | 21 | Female | Face | Western blot |
Normal 10 | 40 | Female | Face | Western blot |
GCMN | Â | |||
GCMN 1 | 8 | Male | Face | LC-MS |
GCMN 2 | 5 | Female | Face | LC-MS |
GCMN 3 | 6 | Female | Face | LC-MS |
GCMN 4 | 8 | Male | Forehead | Western blot |
GCMN 5 | 6 | Female | Abdomen | Western blot |
GCMN 6 | 3 | Female | Left leg | Western blot |
GCMN 7 | 3 | Male | Face | Western blot |
GCMN 8 | 6 | Female | Forehead | Western blot |
GCMN 9 | 7 | Male | Abdomen | Western blot |
GCMN 10 | 6 | Female | Head | Western blot |